Researchers found a small number of clinical trials that indicated antidepressant effects of cytokine blockers.
Researchers found that the inclusion of significant others in cognitive behavioral therapy for victims of violent crimes is beneficial for the victim and indirect victim.
Researchers found no association between depression severity and brain-derived neurotrophic factor (BDNF) levels, and no correlation between BDNF levels and response to electroconvulsive therapy.
Clinicians should be discerning when evaluating meta-analyses of schizophrenia add-on therapies such as statins and antidepressants.
The European Medicine Agency has reported that there may be an association between long-term lithium use and reports of both renal tumors and thyroid cancer.
Given the substantial burden of nonadherence to therapy in patients with schizophrenia, new interventions for compliance are critical.
As depression is one of the most common psychiatric disorders following acute stroke and can be predictive of poor outcomes, identifying biomarkers to recognize the disorder are imperative for improving the clinical course.
The opioid system is responsible for social pain and reward in the brain; therefore, understanding its underpinnings may help clinicians manage patients with depression and suicidal ideation.